A drug that has been used to slow progression of kidney and cardiovascular disease in people with type 2 diabetes may also help people with chronic kidney disease who do not have diabetes, according ...

Please provide your email address to receive an email when new articles are posted on . Patients had lower potassium levels and normokalemia within 15 days of potassium treatment. Patients on ...

Higher serum aldosterone levels among patients with chronic kidney disease (CKD) are independently associated with an increased risk for CKD progression and end-stage kidney disease (ESKD) regardless ...

A steroid hormone called aldosterone is linked to an increased risk of kidney failure in patients with chronic kidney disease (CKD), according to a study published in the European Heart Journal [1] ...

The symptoms of hyperkalemia begin with muscle weakness. As serum potassium levels rise, symptoms progress to more significant muscle twitching, weakness, nausea, and cramping. [69] Cardiac conduction ...

E.D., a 40-year-old man, was first noted to have an elevated blood pressure (240/140) during an insurance examination in January, 1966. The blood pressure was known to have been normal in 1945. In the ...

With almost half of American adults living with high blood pressure, it makes sense that you'd want every possible tool in your arsenal to reduce your numbers and get your blood pressure into a ...

A highly selective aldosterone synthase inhibitor, lorundrostat, showed promise for blood pressure reduction in a double-blind randomized phase IIb trial. Participants with uncontrolled and otherwise ...